Please login to the form below
Titan Pharmaceuticals
This page shows the latest Titan Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
FDA gives green light for opioid addiction implant
Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.
Latest news
-
FDA panel backs approval of first opioid addiction implant
An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... Titan and Braeburn attempted to secure US approval for their product in 2013 but
-
US launch for Novartis' Fanapt
Fanapt was originally developed by Titan Pharmaceuticals, but then under the license agreement from Novartis, Vanda Pharmaceuticals undertook to pursue the drug's phase III development programme and complete product registration. ... America, CEO,
-
Lack of treatments depress EU bladder cancer market
Fenretinide. Vitamin A analogue. NCI. III. Gallium maltolate. Gallium (semi-metalic). Titan Pharmaceuticals. ... DUSA Pharmaceuticals. II. MCC (urocidin). Mycobacterial cell wall-DNA complex. Bioniche Life Sciences.
More from news
Approximately 3 fully matching, plus 1 partially matching documents found.
Latest appointments
-
New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals
Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined Titan Pharmaceuticals’ board of directors, where she currently serves as executive vice president and chief scientific officer. ... DeVarney joined Titan over
-
Ex-Bayer R&D chief joins Gemmus Pharma board
Rubin is currently executive chairman of Titan Pharmaceuticals and previously served as head of global research and development for Bayer Schering Pharma. ... His past positions include chairman of Schering Berlin and president of Schering AG's Berlex
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Moderna to launch Innovation and Technology Center in the UK
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Gilead Sciences supports Kigali Declaration for neglected tropical diseases
- As the NHS turns 74, it launches its ‘biggest NHS Big Tea ever’ to raise funds
- FDA issues innovative proposal to increase nonprescription drug access
- European Commission approves potential new treatment for Pompe disease
- Connect to the conversation around mental health: A spotlight on physician burnout
- How understanding the rare disease patient’s lived experience creates better health communications
- A creative awakening – how pharma is bringing innovation to the patient journey
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Roche shares new positive Ocrevus data for MS patients
- FDA issues innovative proposal to increase nonprescription drug access
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s
PMHub
Origins Insights
Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...
Latest intelligence
- Virtual MSL/Sales training programs and events
- Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
